ELITE PHARMACEUTICALS INC /NV/ Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Elite Pharmaceuticals Inc /Nv/ quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Elite Pharmaceuticals Inc /Nv/ Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$11M, a 174% decline year-over-year.
  • Elite Pharmaceuticals Inc /Nv/ Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$6.39M, a 136% decline year-over-year.
  • Elite Pharmaceuticals Inc /Nv/ annual Net Income (Loss) Attributable to Parent for 2023 was $20.1M, a 465% increase from 2022.
  • Elite Pharmaceuticals Inc /Nv/ annual Net Income (Loss) Attributable to Parent for 2022 was $3.56M, a 60% decline from 2021.
  • Elite Pharmaceuticals Inc /Nv/ annual Net Income (Loss) Attributable to Parent for 2021 was $8.9M, a 74.9% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $20.1M +$16.5M +465% Apr 1, 2023 Mar 31, 2024 10-K 2024-07-01
2022 $3.56M -$5.34M -60% Apr 1, 2022 Mar 31, 2023 10-K 2024-07-01
2021 $8.9M +$3.81M +74.9% Apr 1, 2021 Mar 31, 2022 10-K 2023-06-29
2020 $5.09M +$7.33M Apr 1, 2020 Mar 31, 2021 10-K 2022-06-29
2019 -$2.24M +$7.04M +75.9% Apr 1, 2019 Mar 31, 2020 10-K 2021-06-14
2018 -$9.28M -$5.61M -153% Apr 1, 2018 Mar 31, 2019 10-K 2020-06-30
2017 -$3.67M -$7.48M -196% Apr 1, 2017 Mar 31, 2018 10-K 2019-06-21
2016 $3.81M +$4.49M Apr 1, 2016 Mar 31, 2017 10-K 2018-06-14
2015 -$683K -$5.9M -113% Apr 1, 2015 Mar 31, 2016 10-K 2018-06-14
2014 $5.22M +$46.5M Apr 1, 2014 Mar 31, 2015 10-K 2017-06-14
2013 -$41.3M -$42.7M -2873% Apr 1, 2013 Mar 31, 2014 10-K 2016-06-15
2012 $1.49M +$16.5M Apr 1, 2012 Mar 31, 2013 10-K 2014-06-30
2011 -$15.1M -$1.48M -10.9% Apr 1, 2011 Mar 31, 2012 10-K 2013-06-21
2010 -$13.6M Apr 1, 2010 Mar 31, 2011 10-K 2012-06-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.